Dow Up0.00% Nasdaq Up0.09%

ABIOMED, Inc. (ABMD)

-NasdaqGS
35.52 Down 0.26(0.73%) Nov 28, 1:00PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.2
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:36.17
Median Target:36.00
High Target:43.00
Low Target:31.00
No. of Brokers:6

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Oct 8, 2013The Benchmark CompanyUpgradeSpeculative BuyBuy
Oct 1, 2013The Benchmark CompanyInitiated Speculative Buy
Oct 18, 2012Northland SecuritiesInitiated Under Perform
Aug 15, 2011Rodman & RenshawUpgradeMkt UnderperformMkt Perform
Apr 29, 2011Robert W. BairdUpgradeNeutralOutperform
Dec 9, 2010WunderlichInitiated Buy
Dec 8, 2010Rodman & RenshawDowngradeMkt PerformMkt Underperform
Oct 28, 2010Robert W. BairdInitiated Neutral
May 11, 2010WedbushUpgradeNeutralOutperform
Jan 8, 2010Rodman & RenshawInitiated Mkt Perform

More Upgrades & Downgrades for ABMD

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4555
Buy1111
Hold4333
Underperform1111
Sell0000

Data provided by Thomson/First Call


Currency in USD.